Results 61 to 70 of about 695,872 (210)

Visual Parathyroid Identification in Thyroidectomy: A Decision Curve Analysis of Gland Preservation

open access: yesThe Laryngoscope, EarlyView.
Intraoperative visual identification remains the standard approach to parathyroid preservation during thyroidectomy, yet its accuracy has rarely been quantified against an objective reference. Among 50 suspected parathyroid specimens verified by fine‐needle aspiration PTH washout, expert consensus visual identification achieved 84.0% sensitivity but ...
Paveena Pithuksurachai   +5 more
wiley   +1 more source

Relationship of possible biomarkers with malignancy of thymic tumors: a meta-analysis

open access: yesBMC Cancer, 2020
Background Role of biomarkers for promotion of tumor proliferation (BPTPs) and for promotion of apoptosis (BPAs) in thymic malignant tumors is still unclear.
Huilan Zeng   +7 more
doaj   +1 more source

A spontaneous reduction in tumor size of a thymic carcinoma: a case report

open access: yesSurgical Case Reports, 2022
Background Spontaneous regression of thymic carcinoma is extremely rare. We report a case of a resected thymic carcinoma with preoperative spontaneous regression in a 67-year-old woman.
Shoei Kuroki   +4 more
doaj   +1 more source

Data‐Independent Acquisition Mass Spectrometry in Tumor Classification and Cancer Biomarker Research

open access: yesMass Spectrometry Reviews, EarlyView.
Abstract Cancer treatment is far from optimal also because current classification systems do not reflect the complex molecular status of the tumor and its phenotype in sufficient detail. To construct molecular tumor classifiers, omics tools provide complex molecular data reflecting many aspects from genotype to phenotype.
Jan Simonik   +3 more
wiley   +1 more source

Salvage Chemotherapy in Patients with Previously Treated Thymic Carcinoma

open access: yes, 2021
Thymic carcinoma is a rare neoplasm, and it is difficult to achieve complete remission with systemic chemotherapy. In advanced or recurrent thymic carcinoma, platinum-based chemotherapy is chosen as the first-line setting; however, it remains unclear ...
Hisao Imai   +4 more
core   +1 more source

Trophoblast Cell Surface Antigen 2 Expression in Thymic Carcinoma: Brief Report

open access: yesJTO Clinical and Research Reports
Introduction: Trophoblast cell surface antigen 2 (TROP2) is a transmembrane glycoprotein overexpressed in various cancer types. Although TROP2-targeting therapy is currently attracting attention, little is known about TROP2 expression in thymic carcinoma.
Kana Kurokawa, MD, PhD   +17 more
doaj   +1 more source

Understanding the Type 2 Immunity: An Evolving View Beyond Allergic Diseases

open access: yesAllergy, EarlyView.
ABSTRACT Type 2 (T2) immunity is classically associated with defense against helminths and environmental threats, from a physiological perspective, and with allergies and eosinophilic inflammatory diseases, in a pathological sense. However, growing evidence reveals that T2 pathways also support other essential homeostatic functions, including tissue ...
Rodrigo Jiménez‐Saiz   +22 more
wiley   +1 more source

THYMIC CARCINOMA - A RARE CASE REPORT

open access: yes, 2018
Introduction. Thymic carcinoma is a rare, invasive mediastinal neoplasm with a tendency to metastasize. They constitute a heterogeneous group of tumors that present differently in terms of both behavior and  prognosis. Case report.
Arnav Kr Roychoudhury   +2 more
core   +1 more source

Early-life nutritional and environmental determinants of thymic size in infants born in rural Bangladesh [PDF]

open access: yes, 2009
The aim was to assess the impact of nutritional status and environmental exposures on infant thymic development in the rural Matlab region of Bangladesh.
Collinson, A. C.,   +34 more
core   +1 more source

Salvage surgery for stage IVa thymic carcinoma combined with aortic arch resection – case report

open access: yesJournal of Cardiothoracic Surgery, 2020
Background Although complete surgical resection of thymic carcinoma is a prognostic factor, extended surgery combined with a major blood vessel procedure remains controversial because of the increased risk of mortality.
Hiroyuki Yamato   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy